Myeloproliferative Disorder Treatment Market to Expand at 3.6% CAGR...

added blog Art

2026-08-22 07:51:42 -

Myeloproliferative Disorder Treatment Market to Expand at 3.6% CAGR as JAK Inhibitor Pipeline Advances

Myeloproliferative Disorder Treatment Market to Reach USD 13.13 Billion by 2032, Growing at 3.6% CAGR: Polaris Market Research Myeloproliferative disorders treatment market: According to a new report by Polaris Market Research, the global myeloproliferative disorder treatment market was valued at USD 9.20 billion in 2022 and is projected to reach USD 13.13 billion by 2032, expanding at a CAGR...

0 Comments 0 Shares 69 Views 0 Reviews